z-logo
Premium
Rituximab for chronic inflammatory demyelinating polyneuropathy—A potential therapeutic option
Author(s) -
Cohen Joss C.,
Lewis Richard A.
Publication year - 2020
Publication title -
muscle and nerve
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.26871
Subject(s) - chronic inflammatory demyelinating polyneuropathy , rituximab , medicine , polyneuropathy , immunology , pathology , antibody
See article on pages 575–579 in this issue .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom